Summary & Overview
HCPCS G8473: ACE Inhibitor or ARB Therapy Prescribed
HCPCS Level II code G8473 indicates that an angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) was prescribed for a patient. Nationally, this code captures a common, evidence-based pharmacologic intervention used in hypertension, heart failure, and certain kidney diseases; accurate capture supports quality measurement and care continuity. Key payers included in this analysis are Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare.
Readers will learn what G8473 represents clinically and operationally, how it is used across outpatient and ambulatory settings, and what benchmarks and policy considerations are relevant for payers and providers. The report covers coding context, common modifiers, typical places of service, and the implications for quality reporting and care management workflows. Where input data is incomplete, this summary notes the absence of specific fields. The content aims to help billing managers, clinical leaders, and policy analysts understand the purpose of G8473, typical sites where it is reported, and the payers most commonly engaged with this code at a national level.
Billing Code Overview
HCPCS Level II code G8473 documents that angiotensin converting enzyme (ACE) inhibitor or angiotensin receptor blocker (ARB) therapy was prescribed. This represents a medication-prescribing event for patients for whom ACE inhibitor or ARB therapy is clinically indicated.
Service Type: Prescription/Pharmacologic Management
Typical Site of Service: Outpatient clinic or ambulatory care setting (including primary care and specialty cardiology or nephrology clinics)
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A 62-year-old patient with a history of hypertension and chronic kidney disease stage 3 presents to a primary care clinic for follow-up after hospital discharge for acute myocardial infarction. The clinician reviews current medications, renal function, serum potassium, and blood pressure readings. Based on guideline-directed medical therapy for cardiovascular disease and hypertension control, the clinician prescribes an angiotensin converting enzyme inhibitor (ACE inhibitor) or an angiotensin receptor blocker (ARB) and documents the prescription in the medical record. The typical clinical workflow includes medication reconciliation, assessment of contraindications (history of angioedema, hyperkalemia, pregnancy), review of recent laboratory values (creatinine, eGFR, potassium), counseling on adverse effects and monitoring, electronic prescribing to the patient’s pharmacy, and scheduling follow-up or laboratory monitoring within 1–2 weeks. Typical sites of service are outpatient primary care clinics, cardiology clinics, and transitional care visits after hospital discharge. The service is recorded using billing code G8473 to indicate ACE inhibitor or ARB therapy prescribed as part of quality reporting or performance measures.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
22 | Increased procedural services | Use when documentation supports substantially greater work for counseling or coordination related to initiation of ACE inhibitor/ARB (rare for medication prescription alone). |